Clinical Trial Update: Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing an adjusted brodalumab dose with the standard dose in adults with moderate-to-severe plaque psoriasis and body weight ≥120 kg; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• brodalumab (brodalumab)

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 4 | Status: COMPLETED